SCHEMBL6893076

SCHEMBL6893076

CC(C)(C)CCOc1ccc(OCCC(C)(C)CO)cc1

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HDAC6 Q9UBN7 1/20 0.39
PPARA Q07869 4/20 0.38
NR1I2 O75469 1/20 0.38
ALDH1A1 P00352 1/20 0.36
RECQL P46063 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LTA4H P09960 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
NR5A1 Q13285 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6254887 0.94 CYP3A4 (0.46) CYP3A4SMN1; SMN2PPARANR1I2ALDH1A1
SCHEMBL23539171 0.87 PPARA (0.47) CYP3A4SMN1; SMN2PPARAALDH1A1RECQL
SCHEMBL14524692 0.85 SMN1; SMN2 (0.47) CYP3A4SMN1; SMN2HDAC6PPARAALDH1A1
SCHEMBL11091498 0.82 L3MBTL1 (0.46) CYP3A4SMN1; SMN2PPARAL3MBTL1LTA4H
SCHEMBL6259760 0.81 SMN1; SMN2 (0.41) CYP3A4SMN1; SMN2PPARAALDH1A1L3MBTL1
SCHEMBL11988222 0.80 LTA4H (0.55) CYP3A4SMN1; SMN2HDAC6LTA4HNR5A1
SCHEMBL12868339 0.78 DRD2 (0.52) PPARAL3MBTL1
SCHEMBL483910 0.78 CA12 (0.48) SMN1; SMN2PPARAALDH1A1L3MBTL1MAPT
SCHEMBL27262669 0.77 MCHR1 (0.36) CYP3A4SMN1; SMN2HDAC6ALDH1A1MAPT
SCHEMBL10202971 0.76 CYP1A2 (0.50) SMN1; SMN2ALDH1A1L3MBTL1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004529069-A 2004-09-24 JP claimed
EP-1351916-A2 ETHER COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-10-15 EP claimed
WO-2002030863-A2 ETHER COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO claimed